3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Breast Neoplasms
4
Recurrence
3
Esophageal Squamous Cell Carcinoma
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Ovarian Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Leukemia, Myeloid, Acute
2
Endometrial Neoplasms
2
Carcinoma, Hepatocellular
2
Biliary Tract Neoplasms
2
Barrett Esophagus
2
Adenocarcinoma Of Esophagus
2
Tuberous Sclerosis
1
Solid Tumors
1
Refractory or Relapsed Solid Tumors
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Multiple Myeloma
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Interventions
Paclitaxel
15
Carboplatin
9
liposomal doxorubicin
8
Bevacizumab
8
pembrolizumab
7
Topotecan
6
olaparib
4
mirvetuximab soravtansine
4
Nivolumab
4
Cyclophosphamide
4
niraparib
3
fludarabine
3
Gemcitabine
3
Drug Therapy
3
rucaparib
2
ribociclib
2
pegfilgrastim
2
palbociclib
2
oregovomab
2
fludarabine phosphate
2
Irinotecan
2
Hyperthermic Intraperitoneal Chemotherapy
2
Fulvestrant
2
Cisplatin
2
Blood Specimen Collection
2
1-dodecylpyridoxal
2
trastuzumab deruxtecan
1
sacituzumab govitecan
1
isoquercitrin
1
irinotecan sucrosofate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Ovarian Epithelial
×
Itraconazole
×
1 year
×
Clear all
No trials found.